What is Gocovri used to treat?
Medically reviewed by Drugs.com Last updated on Sep 30, 2019.
Official Answerby Drugs.com
Gocovri (amantadine) extended release capsules are used for treatment of dyskinesia (involuntary movement disorders) in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.
Dyskinesia is often a side effect of levodopa-based Parkinson's disease treatment. Approved in August 2017, it is the first medicine for the treatment of dyskinesia in Parkinson's disease patients.
Related Medical Questions
- What is the difference between Osmolex ER and Gocovri?
- Does Nuplazid treat Parkinson's disease?
- What foods and drugs can't I take with Xadago?